News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yan Leyfman: Great Gene Editing Keynote Highlighting the Promise and Potential of CAR-M Therapy
Yan Leyfman
Jun 17, 2025, 14:45

Yan Leyfman: Great Gene Editing Keynote Highlighting the Promise and Potential of CAR-M Therapy

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on X:

“Great Gene Editing Keynote highlighting the promise and potential of CAR-M at the 2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium by Global Immunotherapy Leader Dr. Saar Gill of University of Pennsylvania.”

Gene Editing

More posts featuring Yan Leyfman.

2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium cancer CAR-M Therapy Gene Editing OncoDaily Oncology Saar Gill University of Pennsylvania Yan Leyfman
Special Coverage
Blog
Jun 17, 2025, 14:45
Yan Leyfman: Great Gene Editing Keynote Highlighting the Promise and Potential of CAR-M Therapy
Blog
Jun 17, 2025, 14:35
Fumiko Ladd Chino: New ASCO Podcast - "Park the Parking"
Blog
Jun 17, 2025, 14:30
Sanofi Presented New Data in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma at EAACI 2025
Opinion
Jun 17, 2025, 14:28
Carmelo Gurnari: What a Nice EHA 2025
Blog
Jun 17, 2025, 14:18
Saleh Alessy: Pleased to See the Launch of The Lancet Oncology Series on Cancer Control
Insight
Jun 17, 2025, 13:50
Penn Medicine - Abramson Cancer Center Shared ASCO25 Study on ctDNA Blood Test For Breast Cancer
Blog
Jun 17, 2025, 12:04
Shehryar Nasir Khawaja: Looking Forward to Presenting Our Work On Postoperative Pain in Head and Neck Cancer Survivors at MASCC 2025
Blog
Jun 17, 2025, 11:38
Erman Akkus: Phase 1 Dual‐dose Escalation Study of Radiation and Nab‐paclitaxel in Pancreatic Cancer
Insight
Jun 17, 2025, 11:22
Dipesh Uprety Highlighted Phase 3 IMforte trial on First-line Maintenance Therapy With Lurbinectedin Plus Atezolizumab in SCLC
Blog
Jun 17, 2025, 11:08
New Funding Opportunity: Quality Improvement Grant Funding From Conquer Cancer's EveryGrant and Pfizer
Opinion
Jun 17, 2025, 10:50
Mark Lewis: New MEN1 Guidelines - My Personal Perspective As a Patient, Parent, and Physician
Insight
Jun 17, 2025, 10:46
LuCE President Debra Montague Will Speak at the First-ever EU Cancer Mission Conference in Warsaw